The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases
03 Jul 2021 10:50 AM
Prof Balram Bhargava said exponential increase in testing has led to early identification, prompt isolation and effective treatment
26 Jun 2021 1:03 PM